Venture(US:VEMLY) Sou Hu Cai Jing·2026-01-13 02:52Group 1 - The core viewpoint of the article highlights the long-term investment opportunities in the medical device sector, driven by innovation, international expansion, and mergers and acquisitions [1] - The medical device sector is experiencing a revaluation as its innovative and international capabilities gain recognition, with a focus on improved and breakthrough innovations that are becoming increasingly acknowledged [1] - By 2026, a turning point is expected in the medical device sector, with opportunities for performance and valuation recovery in individual stocks, particularly those related to overseas expansion and performance recovery [1] Group 2 - The article emphasizes the growing recognition of brain-computer interfaces and AI in healthcare, with significant catalysts in these areas, particularly in consumer health management and AI doctors [1] - The ETF mentioned, Guotai (159377), tracks the Chuangyi Medicine Index (399275), which includes companies with outstanding innovation capabilities and high R&D investment, reflecting the overall performance of high-growth pharmaceutical and biotechnology firms [1] - The medical device sector is anticipated to undergo a dual recovery in valuation and performance, with the potential for several stocks to experience significant growth in the context of a technology bull market [1]